Ligand Pharma (LGND) PT Lifted to $127 at Roth Capital Following Q1 and as Pipeline Expands

Go back to Ligand Pharma (LGND) PT Lifted to $127 at Roth Capital Following Q1 and as Pipeline Expands
LIGAND PHARMA (NASDAQ: LGND) Delayed: 278.50 +16.33 (6.23%)
Previous Close $262.17    52 Week High $139.79 
Open $259.35    52 Week Low $82.07 
Day High $278.78    P/E 647.67 
Day Low $258.00    EPS $0.43 
Volume 1,826,683